Celebrating 33 of Years of MAPS Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD Fully Enrolled April 19, 2019 Dear friends and supporters, MAPS is celebrating 33 years of psychedelic research …
Nine Sites Officially Screening in Phase 3 Clinical Trials of MDMA-Assisted Therapy for PTSD March 20, 2019 Dear friends and supporters, Tremendous growth is happening in the field of psychedelic research. …
Israel Approves Compassionate Use of MDMA-Assisted Therapy for PTSD February 27, 2019 Dear friends and supporters, On February 3, 2019, the Israeli Ministry of Health announced the approval of compassionate …
Eight Sites Officially Screening in Phase 3 Clinical Trials January 28, 2019 Dear friends and supporters, We are excited to announce that eight sites are officially screening for our Phase 3 clinical trial …
Medical-Grade MDMA Arrives at Multiple Phase 3 Clinical Trial Sites Just Five Days Left to Donate to Our Annual Year-End Fundraiser December 26, 2018 Dear friends and supporters, We are amazed by the overwhelming …
MAPS Officially Begins Phase 3 Trials of MDMA-Assisted Therapy for PTSD November 29, 2018 Dear friends and supporters, Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) …
Results Published: Colorado Study Shows Lasting Benefits of MDMA-Assisted Therapy for Treating Chronic PTSD Encouraging results published in the Journal of Psychopharmacology October 30, 2018 Dear friends …
Reduction in Social Anxiety After MDMA-Assisted Therapy with Autistic Adults: A Randomized, Double-Blind, Placebo-Controlled Pilot Study Psychopharmacology publishes MDMA research results September 28, …
Five Study Initiation Visits Completed for Phase 3 Trials of MDMA-Assisted Therapy August 27, 2018 Dear friends and supporters, On August 14 and 15, 2018, the Board of Directors for MAPS and MAPS Public …
Study Initiation Visits Begin for Phase 3 Trials of MDMA-Assisted Therapy July 31, 2018 Dear friends and supporters, Starting in August and September 2018, MAPS will begin the process of screening applications …
European Medicines Agency (EMA) Hosts Scientific Advice Meeting with MAPS June 22, 2018 Dear friends and supporters, This month in London, United Kingdom, MAPS had a successful meeting with the European …
MAPS Schedules Meeting with European Medicines Agency (EMA) May 31, 2018 Dear friends and supporters, This month, The Lancet Psychiatry published results of our pioneering U.S. Food and Drug Administration …